Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua N Liberman

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
BMC Psychiatry|June 2, 2022
Factors associated with COVID-19 Infection among a national population of individuals with schizophrenia or schizoaffective disorder in the United StatesJoshua N Liberman, Jacqueline Pesa, Mary Pat Petrillo, et al.
Neurology|April 10, 2002
Apolipoprotein E epsilon 4 and short-term recovery from predominantly mild brain injuryJoshua N Liberman, Walter F Stewart, Keith Wesnes, et al.
Pharmacoeconomics - Open|February 28, 2022
Implications of Payment for Acute Myocardial Infarctions as a 90-Day Bundled Single Episode of Care: A Cost of Illness AnalysisKeith B Allen, James E Alexander, Joshua N Liberman, et al.
Pharmacoeconomics - Open|September 27, 2022
Correction to: Implications of Payment for Acute Myocardial Infarctions as a 90-Day Bundled Single Episode of Care: A Cost of Illness AnalysisKeith B Allen, James E Alexander, Joshua N Liberman, et al.
Neuropsychiatric Disease and Treatment|November 4, 2022
Measuring Response to Adjunctive Therapy Among Individuals with Major Depressive DisorderFelicia Forma, Joshua N Liberman, Pinyao Rui, et al.
The Journal of Clinical Psychiatry|May 9, 2024
Barriers to Esketamine Nasal Spray Treatment Among Adults With Treatment-Resistant DepressionKruti Joshi, Joshua N Liberman, Purva Parab, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 28, 2023
Real-World Evidence of Aripiprazole Tablets with Sensor: Treatment Patterns and Impacts on Psychiatric Healthcare Resource UtilizationDusica Hadzi Boskovic, Shuting Liang, Purva Parab, et al.
Health Affairs (Project Hope)|January 7, 2011
Medication adherence leads to lower health care use and costs despite increased drug spendingM Christopher Roebuck, Joshua N Liberman, Marin Gemmill-Toyama, et al.
Health Affairs (Project Hope)|July 8, 2011
The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save moneyWilliam H Shrank, Niteesh K Choudhry, Joshua N Liberman, et al.
Journal of the American Pharmacists Association : Japha|January 21, 2011
Revealed preference for community and mail service pharmacyJoshua N Liberman, Yun Wang, David S Hutchins, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
BMC Psychiatry|June 2, 2022
Factors associated with COVID-19 Infection among a national population of individuals with schizophrenia or schizoaffective disorder in the United StatesJoshua N Liberman, Jacqueline Pesa, Mary Pat Petrillo, et al.
Neurology|April 10, 2002
Apolipoprotein E epsilon 4 and short-term recovery from predominantly mild brain injuryJoshua N Liberman, Walter F Stewart, Keith Wesnes, et al.
Pharmacoeconomics - Open|February 28, 2022
Implications of Payment for Acute Myocardial Infarctions as a 90-Day Bundled Single Episode of Care: A Cost of Illness AnalysisKeith B Allen, James E Alexander, Joshua N Liberman, et al.
Pharmacoeconomics - Open|September 27, 2022
Correction to: Implications of Payment for Acute Myocardial Infarctions as a 90-Day Bundled Single Episode of Care: A Cost of Illness AnalysisKeith B Allen, James E Alexander, Joshua N Liberman, et al.
Neuropsychiatric Disease and Treatment|November 4, 2022
Measuring Response to Adjunctive Therapy Among Individuals with Major Depressive DisorderFelicia Forma, Joshua N Liberman, Pinyao Rui, et al.
The Journal of Clinical Psychiatry|May 9, 2024
Barriers to Esketamine Nasal Spray Treatment Among Adults With Treatment-Resistant DepressionKruti Joshi, Joshua N Liberman, Purva Parab, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 28, 2023
Real-World Evidence of Aripiprazole Tablets with Sensor: Treatment Patterns and Impacts on Psychiatric Healthcare Resource UtilizationDusica Hadzi Boskovic, Shuting Liang, Purva Parab, et al.
Health Affairs (Project Hope)|January 7, 2011
Medication adherence leads to lower health care use and costs despite increased drug spendingM Christopher Roebuck, Joshua N Liberman, Marin Gemmill-Toyama, et al.
Health Affairs (Project Hope)|July 8, 2011
The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save moneyWilliam H Shrank, Niteesh K Choudhry, Joshua N Liberman, et al.
Journal of the American Pharmacists Association : Japha|January 21, 2011
Revealed preference for community and mail service pharmacyJoshua N Liberman, Yun Wang, David S Hutchins, et al.
Pageof 5